0.07% -0.010

Handel nachbörslich: 14.50

Cadrenal Therapeutics Inc (CVKD)

Cadrenal Therapeutics Inc Aktie (CVKD) Neueste Nachrichten

Cadrenal Therapeutics Inc (CVKD)

Cadrenal Therapeutics Inc Aktie (CVKD) Neueste Nachrichten

Where are the Opportunities in (CVKD) - Stock Traders Daily

Cadrenal Therapeutics Unveils Phase 3 Trials and Market Strategy - TipRanks

Cadrenal Therapeutics to Participate in Lytham Partners Fall 2024 Investor Conference - PR Newswire

Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) Forecasted to Earn Q3 2024 Earnings of ($2.18) Per Share - MarketBeat

Applied Therapeutics (NASDAQ:APLT) Trading Down 4.1% - Defense World

WATCH LIVE: Fed Chair Jerome Powell speaks after a 50bp interest rate cut - Investing.com

Cancer Biotech Nuvalent’s Stock Jumps on Positive Data - MSN

Cadrenal Therapeutics (CVKD) Stock Rallies In After-Market Trading Ahead Of Regulatory Meeting - Stocks Telegraph

Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) Short Interest Update - MarketBeat

Eli Lilly invests $1.8B to boost manufacturing footprint in Ireland - MSN

Cadrenal Therapeutics regains Nasdaq compliance - Investing.com India

Cadrenal Therapeutics regains Nasdaq compliance - Investing.com

Cadrenal gears up for FDA talks on heart drug trial - Investing.com India

Cadrenal gears up for FDA talks on heart drug trial - Investing.com

Cadrenal Therapeutics Announces Upcoming Type-B FDA Meeting in September to Discuss Tecarfarin Trial in LVAD Patients - PR Newswire

Published Findings Highlight Tecarfarin's Potential and Reinforce Need for Better Anticoagulation Therapy in LVAD Patients - PR Newswire

Upcoming Stock Splits This Week (August 19 to August 23) – Stay InvestingTHE BHARAT EXPRESS NEWS - The Bharat Express News

Upcoming Stock Splits This Week (August 19 to August 23) – Stay Invested - MSN

Upcoming Stock Splits This Week (August 19 to August 23) – Stay Invested - Yahoo Finance

Upcoming Stock Splits This Week (August 19 to August 23) – Stay Invested - Nasdaq

Cadrenal announces 1-for-15 reverse stock split By Investing.com - Investing.com Australia

Cadrenal announces 1-for-15 reverse stock split - Investing.com

Cadrenal announces 1-for-15 reverse stock split By Investing.com - Investing.com UK

Cadrenal announces 1-for-15 reverse stock split By Investing.com - Investing.com Canada

Cadrenal Therapeutics Inc: Analyzing CVKD Stock Trends - The InvestChronicle

CVKDCadrenal Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Cadrenal Therapeutics to Present at Upcoming Investor Conferences - Longview News-Journal

Cadrenal Therapeutics to Present at Upcoming Investor Conferences - StockTitan

Cadrenal Therapeutics, Inc. (CVKD): A New Penny Stock to Buy Now - Yahoo Finance

Q3 2024 Earnings Estimate for Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) Issued By HC Wainwright - Defense World

10 Best New Penny Stocks To Buy Now - Insider Monkey

CVKD Stock Earnings: Cadrenal Therapeutics Misses EPS for Q2 2024 - InvestorPlace

Cadrenal Therapeutics Provides Second Quarter 2024 Corporate Update - PR Newswire

CVKD: Cadrenal Therapeutics and Abbott Collaborate on Novel Anticoagulant for LVAD Patients - Zacks Small Cap Research

CVKD: Cadrenal Therapeutics and Abbott Collaborate on Novel Anticoagulant for LVAD Patients - Yahoo Finance

Cadrenal Therapeutics Inc (CVKD) Stock: Exploring a Year of Highs, Lows, and Trading Volume - The InvestChronicle

CVKD’s price-to-free cash flow ratio: A closer look at its relevance - US Post News

Cadrenal Therapeutics Partners with Abbott on Cardiac Trial - TipRanks

Ponte Vedra-based Cadrenal Therapeutics in talks for partnership with Abbott - Jacksonville Business Journal

Cadrenal Therapeutics and Abbott Initiate Collaborative Effort to Advance Novel Anticoagulant Tecarfarin for Patients with LVADs - PR Newswire

Cadrenal Therapeutics announces stock incentive plan expansion - Investing.com

Cadrenal Therapeutics announces stock incentive plan expansion - Investing.com India

Cadrenal Therapeutics announces stock incentive plan expansion By Investing.com - Investing.com Australia

Cadrenal Therapeutics announces stock incentive plan expansion By Investing.com - Investing.com Nigeria

Cadrenal Therapeutics Enhances Incentives and Adjusts Stock Plan - TipRanks

Cadrenal Therapeutics to Present at the Emerging Growth Conference on July 18, 2024 - Victoria Advocate

Cadrenal Therapeutics to Present at the Emerging Growth Conference on July 18, 2024 - StockTitan

Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now - GlobeNewswire Inc.

Cadrenal drug moving closer to FDA approval - Jacksonville Daily Record

Cadrenal drug moving closer to FDA approval | Jax Daily Record - Jacksonville Daily Record

Cadrenal Therapeutics to Present at the Emerging Growth Conference on June 12, 2024 - Longview News-Journal

Cadrenal Therapeutics to Present at the Emerging Growth Conference on June 12, 2024 - StockTitan

HC Wainwright Research Analysts Reduce Earnings Estimates for Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) - Defense World

Cadrenal Therapeutics' (CVKD) Buy Rating Reaffirmed at HC Wainwright - Defense World

Cadrenal Therapeutics Highlights Presentation of New Trial Data at ISHLT Conference Demonstrating the Importance ... - PR Newswire

Cadrenal Therapeutics Highlights Presentation of New Trial Data at ISHLT Conference Demonstrating the Importance of Anticoagulation Quality in LVAD Patients - PR Newswire

Cadrenal Therapeutics to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024 - PR Newswire

Cadrenal Therapeutics to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024 - Longview News-Journal

Insider Buyers Lose Additional US$57k As Cadrenal Therapeutics Dips To US$7.0m - Simply Wall St

Cadrenal Therapeutics (NASDAQ:CVKD) Earns Buy Rating from HC Wainwright - Defense World

Cadrenal Therapeutics Provides First Quarter 2024 Corporate Update - PR Newswire

Cadrenal Therapeutics Provides First Quarter 2024 Corporate UpdateInvesting.com ZA - Investing.com South Africa

Ähnlich wie CVKD